Sections
| Title | Starting Page | Number of Pages |
|---|
| Table of Contents | 2 | 4 |
| List of Tables | 4 | 1 |
| List of Figures | 5 | 1 |
| University of Cambridge, Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 2016 | 5 | 2 |
| University of Cambridge, Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 2016 | 7 | 1 |
| University of Cambridge, Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 2016 | 8 | 1 |
| University of Cambridge, Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 2016 | 9 | 1 |
| University of Cambridge, Medical Devices Deals, 2010 to YTD 2016 | 10 | 1 |
| University of Cambridge, Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 2016 | 11 | 3 |
| University of Cambridge, Pharmaceuticals &Healthcare, Deal Details | 14 | 32 |
| Venture Financing | 14 | 1 |
| DefiniGEN Raises USD2.2 Million in Venture Financing | 14 | 2 |
| Cambridge Epigenetix Raises USD21 Million in Series B Financing | 16 | 1 |
| Quethera Raises Funds in Seed Financing Round | 17 | 1 |
| PhoreMost Raises USD3.8 Million in Seed Financing | 18 | 1 |
| Fluidic Analytics Raises USD2.4 Million in Series A Venture Financing | 19 | 2 |
| Cambridge Epigenetix Raises USD5.5 Million in Series A Venture Financing | 21 | 1 |
| DefiniGEN Raises USD3.8 Million in Series A Financing | 22 | 2 |
| Sphere Fluidics Raises US$2.5 Million In Venture Financing | 24 | 2 |
| Sphere Fluidics Raises Funds through Seed Financing | 26 | 1 |
| Partnerships | 27 | 1 |
| Genestack Partners with Cancer Molecular Diagnostic Laboratory | 27 | 1 |
| OncoTherics Enters into Agreement with University of Cambridge | 28 | 1 |
| AstraZeneca and MedImmune Enter into R&D Agreement with University of Cambridge | 29 | 2 |
| MedImmune Enters Into Research Agreement With Cambridge University | 31 | 1 |
| GlaxoSmithKline Enters Into Co-Development Agreement With University of Cambridge | 32 | 1 |
| University of Cambridge Enters Into Joint Venture Agreement With Elan | 33 | 1 |
| Phylogica Enters Into Joint Venture Agreement With University Of Cambridge | 34 | 1 |
| AstraZeneca Enters Into Joint Venture With Sanofi, University Of Cambridge, EPFL, And Universities Of Pavia And Uppsala | 35 | 2 |
| Licensing Agreements | 37 | 1 |
| Cantabio Pharma Enters into Licensing Agreement with University of Cambridge | 37 | 1 |
| DefiniGEN Enters into Licensing Agreement with University of Cambridge | 38 | 1 |
| Sphere Fluidics Enters Into Licensing Agreement with Cambridge University for Picodroplets | 39 | 1 |
| Sphere Fluidics Enters Into Licensing Agreement with Cambridge University | 40 | 1 |
| Acquisition | 41 | 1 |
| Nihon Trim To Acquire 50.1% Stake In StemCell Institute For US$5.3 Million | 41 | 1 |
| SuperGen Completes Acquisition Of Astex Therapeutics | 42 | 4 |
| University of Cambridge - Key Competitors | 46 | 1 |
| Key Employees | 47 | 1 |
| Locations And Subsidiaries | 48 | 2 |
| Head Office | 48 | 1 |
| Other Locations &Subsidiaries | 48 | 2 |
| Appendix | 50 | 1 |
| Methodology | 50 | 1 |
| About GlobalData | 50 | 1 |
| Contact Us | 50 | 1 |
| Disclaimer | 50 | 1 |